PHD3 transcript levels were shown to be increased in HNSCC, and in vitro analysis revealed inhibition of cell cycle progression in cancerous cells in the absence of PHD3 activity [45]. This evidence concerns the gene EGLN3 and head and neck squamous cell carcinoma.